Global Psoriasis Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Psoriasis Drug

• 1.1 Definition of Psoriasis Drug
• 1.2 Psoriasis Drug Segment by Type
  • 1.2.1 Global Psoriasis Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 External Use
  • 1.2.3 Oral
  • 1.2.4 Injection
• 1.3 Psoriasis Drug Segment by Applications
  • 1.3.1 Global Psoriasis Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Drugs Store
• 1.4 Global Psoriasis Drug Overall Market
  • 1.4.1 Global Psoriasis Drug Revenue (2014-2025)
  • 1.4.2 Global Psoriasis Drug Production (2014-2025)
  • 1.4.3 North America Psoriasis Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Psoriasis Drug Status and Prospect (2014-2025)
  • 1.4.5 China Psoriasis Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Psoriasis Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Psoriasis Drug Status and Prospect (2014-2025)
  • 1.4.8 India Psoriasis Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Psoriasis Drug
• 2.3 Manufacturing Process Analysis of Psoriasis Drug
• 2.4 Industry Chain Structure of Psoriasis Drug

3 Development and Manufacturing Plants Analysis of Psoriasis Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Psoriasis Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Psoriasis Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Psoriasis Drug Production and Capacity Analysis
• 4.2 Psoriasis Drug Revenue Analysis
• 4.3 Psoriasis Drug Price Analysis
• 4.4 Market Concentration Degree

5 Psoriasis Drug Regional Market Analysis

• 5.1 Psoriasis Drug Production by Regions
  • 5.1.1 Global Psoriasis Drug Production by Regions
  • 5.1.2 Global Psoriasis Drug Revenue by Regions
• 5.2 Psoriasis Drug Consumption by Regions
• 5.3 North America Psoriasis Drug Market Analysis
  • 5.3.1 North America Psoriasis Drug Production
  • 5.3.2 North America Psoriasis Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Psoriasis Drug Import and Export
• 5.4 Europe Psoriasis Drug Market Analysis
  • 5.4.1 Europe Psoriasis Drug Production
  • 5.4.2 Europe Psoriasis Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Psoriasis Drug Import and Export
• 5.5 China Psoriasis Drug Market Analysis
  • 5.5.1 China Psoriasis Drug Production
  • 5.5.2 China Psoriasis Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Psoriasis Drug Import and Export
• 5.6 Japan Psoriasis Drug Market Analysis
  • 5.6.1 Japan Psoriasis Drug Production
  • 5.6.2 Japan Psoriasis Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Psoriasis Drug Import and Export
• 5.7 Southeast Asia Psoriasis Drug Market Analysis
  • 5.7.1 Southeast Asia Psoriasis Drug Production
  • 5.7.2 Southeast Asia Psoriasis Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Psoriasis Drug Import and Export
• 5.8 India Psoriasis Drug Market Analysis
  • 5.8.1 India Psoriasis Drug Production
  • 5.8.2 India Psoriasis Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Psoriasis Drug Import and Export

6 Psoriasis Drug Segment Market Analysis (by Type)

• 6.1 Global Psoriasis Drug Production by Type
• 6.2 Global Psoriasis Drug Revenue by Type
• 6.3 Psoriasis Drug Price by Type

7 Psoriasis Drug Segment Market Analysis (by Application)

• 7.1 Global Psoriasis Drug Consumption by Application
• 7.2 Global Psoriasis Drug Consumption Market Share by Application (2014-2019)

8 Psoriasis Drug Major Manufacturers Analysis

• 8.1 AbbVie
  • 8.1.1 AbbVie Psoriasis Drug Production Sites and Area Served
  • 8.1.2 AbbVie Product Introduction, Application and Specification
  • 8.1.3 AbbVie Psoriasis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Johnson & Johnson
  • 8.2.1 Johnson & Johnson Psoriasis Drug Production Sites and Area Served
  • 8.2.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.2.3 Johnson & Johnson Psoriasis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Bayer
  • 8.3.1 Bayer Psoriasis Drug Production Sites and Area Served
  • 8.3.2 Bayer Product Introduction, Application and Specification
  • 8.3.3 Bayer Psoriasis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Galderma
  • 8.4.1 Galderma Psoriasis Drug Production Sites and Area Served
  • 8.4.2 Galderma Product Introduction, Application and Specification
  • 8.4.3 Galderma Psoriasis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Bristol-Myers Squibb
  • 8.5.1 Bristol-Myers Squibb Psoriasis Drug Production Sites and Area Served
  • 8.5.2 Bristol-Myers Squibb Product Introduction, Application and Specification
  • 8.5.3 Bristol-Myers Squibb Psoriasis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Novartis
  • 8.6.1 Novartis Psoriasis Drug Production Sites and Area Served
  • 8.6.2 Novartis Product Introduction, Application and Specification
  • 8.6.3 Novartis Psoriasis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Pfizer
  • 8.7.1 Pfizer Psoriasis Drug Production Sites and Area Served
  • 8.7.2 Pfizer Product Introduction, Application and Specification
  • 8.7.3 Pfizer Psoriasis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Merz Pharma
  • 8.8.1 Merz Pharma Psoriasis Drug Production Sites and Area Served
  • 8.8.2 Merz Pharma Product Introduction, Application and Specification
  • 8.8.3 Merz Pharma Psoriasis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Valeant
  • 8.9.1 Valeant Psoriasis Drug Production Sites and Area Served
  • 8.9.2 Valeant Product Introduction, Application and Specification
  • 8.9.3 Valeant Psoriasis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 LEO Pharma
  • 8.10.1 LEO Pharma Psoriasis Drug Production Sites and Area Served
  • 8.10.2 LEO Pharma Product Introduction, Application and Specification
  • 8.10.3 LEO Pharma Psoriasis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 GlaxoSmithKline

9 Development Trend of Analysis of Psoriasis Drug Market

• 9.1 Global Psoriasis Drug Market Trend Analysis
  • 9.1.1 Global Psoriasis Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Psoriasis Drug Regional Market Trend
  • 9.2.1 North America Psoriasis Drug Forecast 2019-2025
  • 9.2.2 Europe Psoriasis Drug Forecast 2019-2025
  • 9.2.3 China Psoriasis Drug Forecast 2019-2025
  • 9.2.4 Japan Psoriasis Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Psoriasis Drug Forecast 2019-2025
  • 9.2.6 India Psoriasis Drug Forecast 2019-2025
• 9.3 Psoriasis Drug Market Trend (Product Type)
• 9.4 Psoriasis Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Psoriasis Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List